Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ivy Carroll

Showing results (111-120 of 186) with videos related to

Pageof 19
Sort By:
ACS Chemical Neuroscience|August 30, 2018
Synthesis and Characterization of the Selective, Reversible PKC<sub>β</sub> Inhibitor (9 S)-9-[(Dimethylamino)methyl]-6,7,10,11-tetrahydro-9 H,18 H-5,21:12,17-dimethenodibenzo[ e,k]pyrrolo[3,4- h][1,4,13]oxadiazacyclohexadecine-18,20(19 H)-dione, Ruboxistaurin (LY333531)Anita H Lewin, Larry Brieaddy, Jeffrey R Deschamps, et al.
Molecular Pharmacology|July 3, 2015
Quantitative Signaling and Structure-Activity Analyses Demonstrate Functional Selectivity at the Nociceptin/Orphanin FQ Opioid ReceptorSteven D Chang, S Wayne Mascarella, Skylar M Spangler, et al.
Journal of Medicinal Chemistry|November 10, 2010
Nicotinic acetylcholine receptor efficacy and pharmacological properties of 3-(substituted phenyl)-2β-substituted tropanesF Ivy Carroll, Bruce E Blough, S Wayne Mascarella, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2023
Cognitive-Enhancing Effects of Acetylcholine Receptor Agonists in Group-Housed Cynomolgus Monkeys Who Drink EthanolLindsey K Galbo-Thomma, Phillip M Epperly, Bruce E Blough, et al.
Neuropharmacology|March 11, 2017
In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependenceAsti Jackson, Deniz Bagdas, Pretal P Muldoon, et al.
European Journal of Pharmacology|February 15, 2003
Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in ratsKelly A Byrnes-Blake, Elizabeth M Laurenzana, F Ivy Carroll, et al.
Journal of Medicinal Chemistry|February 18, 2010
Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessationF Ivy Carroll, Bruce E Blough, S Wayne Mascarella, et al.
Journal of Medicinal Chemistry|October 4, 2002
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analoguesF Ivy Carroll, Jeffrey R Lee, Hernán A Navarro, et al.
BMC Pharmacology|May 31, 2012
Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicityThomas A Munro, Loren M Berry, Ashlee Van't Veer, et al.
Pharmacology, Biochemistry, and Behavior|November 26, 2021
Blockade of kappa-opioid receptors amplifies microglia-mediated inflammatory responsesGalen Missig, Emma L Fritsch, Niyati Mehta, et al.
Pageof 19

Showing results (111-120 of 186) with videos related to

Sort By:
Pageof 19
ACS Chemical Neuroscience|August 30, 2018
Synthesis and Characterization of the Selective, Reversible PKC<sub>β</sub> Inhibitor (9 S)-9-[(Dimethylamino)methyl]-6,7,10,11-tetrahydro-9 H,18 H-5,21:12,17-dimethenodibenzo[ e,k]pyrrolo[3,4- h][1,4,13]oxadiazacyclohexadecine-18,20(19 H)-dione, Ruboxistaurin (LY333531)Anita H Lewin, Larry Brieaddy, Jeffrey R Deschamps, et al.
Molecular Pharmacology|July 3, 2015
Quantitative Signaling and Structure-Activity Analyses Demonstrate Functional Selectivity at the Nociceptin/Orphanin FQ Opioid ReceptorSteven D Chang, S Wayne Mascarella, Skylar M Spangler, et al.
Journal of Medicinal Chemistry|November 10, 2010
Nicotinic acetylcholine receptor efficacy and pharmacological properties of 3-(substituted phenyl)-2β-substituted tropanesF Ivy Carroll, Bruce E Blough, S Wayne Mascarella, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2023
Cognitive-Enhancing Effects of Acetylcholine Receptor Agonists in Group-Housed Cynomolgus Monkeys Who Drink EthanolLindsey K Galbo-Thomma, Phillip M Epperly, Bruce E Blough, et al.
Neuropharmacology|March 11, 2017
In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependenceAsti Jackson, Deniz Bagdas, Pretal P Muldoon, et al.
European Journal of Pharmacology|February 15, 2003
Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in ratsKelly A Byrnes-Blake, Elizabeth M Laurenzana, F Ivy Carroll, et al.
Journal of Medicinal Chemistry|February 18, 2010
Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessationF Ivy Carroll, Bruce E Blough, S Wayne Mascarella, et al.
Journal of Medicinal Chemistry|October 4, 2002
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analoguesF Ivy Carroll, Jeffrey R Lee, Hernán A Navarro, et al.
BMC Pharmacology|May 31, 2012
Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicityThomas A Munro, Loren M Berry, Ashlee Van't Veer, et al.
Pharmacology, Biochemistry, and Behavior|November 26, 2021
Blockade of kappa-opioid receptors amplifies microglia-mediated inflammatory responsesGalen Missig, Emma L Fritsch, Niyati Mehta, et al.
Pageof 19